Merck & Company Inc (MRK)vsPetMed Express Inc (PETS)
MRK
Merck & Company Inc
$143.93
-0.54%
HEALTHCARE · Cap: $355.10B
PETS
PetMed Express Inc
$1.65
-2.94%
HEALTHCARE · Cap: $39.24M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 39324% more annual revenue ($66.57B vs $168.86M). MRK leads profitability with a 4.8% profit margin vs -17.3%. PETS appears more attractively valued with a PEG of 2.32. PETS earns a higher WallStSmart Score of 43/100 (D).
MRK
Hold36
out of 100
Grade: F
PETS
Hold43
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.7%
Fair Value
$82.84
Current Price
$143.93
$61.09 premium
Margin of Safety
+70.8%
Fair Value
$10.16
Current Price
$1.65
$8.51 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Earnings expanding 266.7% YoY
Conservative balance sheet, low leverage
Reasonable price relative to book value
Areas to Watch
Trading at 8.5x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Expensive relative to growth rate
Smaller company, higher risk/reward
Weak financial health signals
ROE of -100.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : PETS
The strongest argument for PETS centers on EPS Growth, Debt/Equity, Price/Book.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 116.1x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : PETS
The primary concerns for PETS are PEG Ratio, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
MRK profiles as a value stock while PETS is a turnaround play — different risk/reward profiles.
PETS carries more volatility with a beta of 0.79 — expect wider price swings.
MRK is growing revenue faster at 5.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
PETS scores higher overall (43/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →PetMed Express Inc
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?